Medifast (MED) Long-Term Deferred Tax (2017 - 2025)

Medifast's Long-Term Deferred Tax history runs 9 years deep, the most recent figure standing at $12.1 million for Q3 2025.

• Quarterly Long-Term Deferred Tax rose 202.55% year-over-year to $12.1 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $12.1 million (up 202.55% YoY) and the FY2024 annual result came in at $11.5 million, up 178.36% from the prior year.
• Long-Term Deferred Tax was $12.1 million for Q3 2025 at Medifast, up from $11.5 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $12.1 million in Q3 2025 and bottomed at $692000.0 in Q1 2021.
• A 5-year average of $5.8 million and a median of $4.4 million in 2021 frame the typical range for Long-Term Deferred Tax.
• Annual changes were most pronounced in 2021 — Long-Term Deferred Tax tumbled 66.59% — and 2022, when it jumped 788.73%.
• Medifast's Long-Term Deferred Tax stood at $4.4 million in 2021, then grew by 20.98% to $5.3 million in 2022, then fell by 22.73% to $4.1 million in 2023, then jumped by 178.36% to $11.5 million in 2024, then climbed by 5.65% to $12.1 million in 2025.
• Business Quant data shows MED's Long-Term Deferred Tax at $12.1 million in Q3 2025, $11.5 million in Q2 2025, and $11.4 million in Q1 2025.